Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

Research and Development (R&D) Expenses: R&D expenses were $16.0 million for the three months ended September 30, 2024, as compared to $14.0 million for the same period in 2023. The increase was ...

University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

The recent update to South Africa’s health-research ethics guidelines on heritable human genome editing has ignited ...

To separate AI hype from reality in medicine, a doctor and author of a book on generative AI’s future in medicine suggests asking three simple questions.

Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...

Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA to proteins. But only two percent of the human genome actually encodes ...

Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs ...